Back
ESC Professional Premium Access

Does dulaglutide impact a composite outcome reflecting atherosclerosis? A post-hoc analysis of the REWIND trial

Session: Diabetes and the Heart 3
Topic: Diabetes and the Heart
Speaker: Doctor G. Ferrannini (Stockholm, SE)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Giulia Ferrannini

Karolinska Institute, Stockholm (Sweden)
2 presentations
0 follower

5 more presentations in this session

Comparison of mechanistic pathways of metabolic bariatric surgery in diabetic patients

Speaker: Doctor N. Chew (Singapore, SG)

Access
Abstract
Slides
Like
Thumbnail

The effects of colchicine in patients with diabetes mellitus and chronic coronary artery disease: a post-hoc analysis of the LoDoCo2-trial

Speaker: Mr N. Mohammadnia (Nijmegen, NL)

Access
Abstract
Slides
Like
Thumbnail

Causes of excess mortality in diabetes patients without coronary artery disease

Speaker: Doctor K. Olesen (Aarhus, DK)

Access
Abstract
Slides
Like
Thumbnail

Association of hepatic steatosis with subclinical cardiac dysfunction in asymptomatic people with type 2 diabetes

Speaker: Doctor J. Yeo (Leicester, GB)

Access
Abstract
Slides
Like
Thumbnail

Non-dipping heart rate & major adverse cardiovascular events in type 2 diabetes mellitus

Speaker: Doctor L. Vassallo (Msida, MT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Diabetes and the Heart 3

Speakers: Doctor G. Ferrannini, Doctor N. Chew, Mr N. Mohammadnia, Doctor K. Olesen, Doctor J. Yeo...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources